FUFadil Umihanic

Fadil Umihanic

*This is an algorithmically generated author record based on publicly available information.

Fadil Umihanic has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Outcome of Multiple Combined Post-bariatric Surgery in Massive Weight Loss Patients

    by Mufid Burgic, Anadi Begic, Adi Rifatbegovic, Musfaha Burgic, Fadil Umihanic

    The growing popularity of bariatric surgery has resulted in a rising demand for body contouring procedures to address excess skin and reshape the body after massive weight loss (MWL). Performing multiple procedures in a single operative session may shorten the overall recovery period and enhance patient satisfaction. The aim of this study was to present our outcomes with combined body contouring procedures in post-MWL patients, evaluate long-term aesthetic results, and compare our findings with outcomes reported in the literature. A total of 75 patients who experienced significant weight loss underwent multiple combined body contouring surgery from May 2018-May 2024. Each patient received two or three procedures as a single stage. The surgical interventions included lower trunk lift with or without gluteal autoaugmentation, upper trunk lift (brachioplasty combined with mastopexy or gynecomastia correction), and thigh lift. Patient satisfaction was assessed six months postoperatively using a structured questionnaire. Patients ranged in age from 17 to 58 years, with a mean age of 32 years. The overall complication rate was low: minor wound dehiscence occurred in 9.33% of cases (n=7), seroma formation in 8% (n=6), wound infection in 5.33% (n=4), and hematoma in 2.66% (n=2), the latter requiring readmission. No operative time exceeded 4.5 hours. Patient-reported satisfaction with aesthetic outcomes was high across all domains assessed. Patient satisfaction with multiple combined body contouring procedures following MWL was good/excellent. Performing these surgeries in a single stage proved to be efficient and well-tolerated. Successful outcomes require careful patient selection, detailed surgical planning, and seamless multidisciplinary collaboration to minimize complications and optimize recovery. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

  • Open Access

    Evaluating the Concordance Between ChatGPT and Multidisciplinary Teams in Breast Cancer Treatment Planning: A Study from Bosnia and Herzegovina

    by Sefika Umihanic, Hedim Osmanovic, Nejra Selak, Dijana Kopric, Asija Huseinbasic, Erna Sehic-Kozica, Belma Babic, Fadil Umihanic

    Background/Objectives: In many low- and middle-income countries (LMICs), including Bosnia and Herzegovina, oncology services are constrained by a limited number of specialists and uneven access to evidence-based care. Artificial intelligence (AI), particularly large language models (LLMs) such as ChatGPT, may provide clinical decision support to help standardize treatment and assist clinicians where oncology expertise is scarce. This study aimed to evaluate the concordance, safety, and clinical appropriateness of ChatGPT-generated treatment recommendations compared to decisions made by a multidisciplinary team (MDT) in the management of newly diagnosed breast cancer patients. Methods: This retrospective study included 91 patients with newly diagnosed, treatment-naïve breast cancer, presented to an MDT in Bosnia and Herzegovina in 2023. Patient data were entered into ChatGPT-4.0 to generate treatment recommendations. Four board-certified oncologists, two internal and two external, evaluated ChatGPT’s suggestions against MDT decisions using a 4-point Likert scale. Agreement was analyzed using descriptive statistics, Cronbach’s alpha, and Fleiss’ kappa. Results: The mean agreement score between ChatGPT and MDT decisions was 3.31 (SD = 0.10), with high consistency across oncologist ratings (Cronbach’s alpha = 0.86). Fleiss’ kappa indicated moderate inter-rater reliability (κ = 0.31, p < 0.001). Higher agreement was observed in patients with hormone receptor-negative tumors and those treated with standard chemotherapy regimens. Lower agreement occurred in cases requiring individualized decisions, such as low-grade tumors or uncertain indications for surgery or endocrine therapy. Conclusions: ChatGPT showed high concordance with MDT treatment plans, especially in standardized clinical scenarios. In resource-limited settings, AI tools may support oncology decision-making and help bridge gaps in clinical expertise. However, careful validation and expert oversight remain essential for safe and effective use in practice.